These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 31694035
1. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery. Jung TY, Jung S, Ryu HS, Kim IY, Jang WY, Moon KS, Lim SH, Kim DY, Kang SR, Min JJ, Bom HS, Kim SK, Kwon SY. Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035 [Abstract] [Full Text] [Related]
2. Quantitative Feasibility Evaluation of 11C-Methionine Positron Emission Tomography Images in Gamma Knife Radiosurgery : Phantom-Based Study and Clinical Application. Lim SH, Jung TY, Jung S, Kim IY, Moon KS, Kwon SY, Jang WY. J Korean Neurosurg Soc; 2019 Jul; 62(4):476-486. PubMed ID: 31154754 [Abstract] [Full Text] [Related]
3. A fully automatic approach for multimodal PET and MR image segmentation in gamma knife treatment planning. Rundo L, Stefano A, Militello C, Russo G, Sabini MG, D'Arrigo C, Marletta F, Ippolito M, Mauri G, Vitabile S, Gilardi MC. Comput Methods Programs Biomed; 2017 Jun; 144():77-96. PubMed ID: 28495008 [Abstract] [Full Text] [Related]
4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S, Ohata K, Goto T, Hara M. J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366 [Abstract] [Full Text] [Related]
5. Clinical value of [¹¹C]methionine PET for stereotactic radiation therapy with intensity modulated radiation therapy to metastatic brain tumors. Miwa K, Matsuo M, Shinoda J, Aki T, Yonezawa S, Ito T, Asano Y, Yamada M, Yokoyama K, Yamada J, Yano H, Iwama T. Int J Radiat Oncol Biol Phys; 2012 Dec 01; 84(5):1139-44. PubMed ID: 22520479 [Abstract] [Full Text] [Related]
6. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma. Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Nishikawa M, Ohata K, Torii K, Morino M, Nishio A, Hara M. Ann Nucl Med; 2004 Jun 01; 18(4):291-6. PubMed ID: 15359921 [Abstract] [Full Text] [Related]
7. Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Astner ST, Dobrei-Ciuchendea M, Essler M, Bundschuh RA, Sai H, Schwaiger M, Molls M, Weber WA, Grosu AL. Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1161-7. PubMed ID: 18440729 [Abstract] [Full Text] [Related]
8. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases. Momose T, Nariai T, Kawabe T, Inaji M, Tanaka Y, Watanabe S, Maehara T, Oda K, Ishii K, Ishiwata K, Yamamoto M. Clin Nucl Med; 2014 Nov 15; 39(11):939-43. PubMed ID: 25140562 [Abstract] [Full Text] [Related]
9. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. Grosu AL, Weber WA, Astner ST, Adam M, Krause BJ, Schwaiger M, Molls M, Nieder C. Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):339-44. PubMed ID: 16765533 [Abstract] [Full Text] [Related]
10. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC-Preliminary Results. Tomura N, Kokubun M, Saginoya T, Mizuno Y, Kikuchi Y. AJNR Am J Neuroradiol; 2017 Aug 01; 38(8):1520-1527. PubMed ID: 28619837 [Abstract] [Full Text] [Related]
11. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading. Wu R, Watanabe Y, Arisawa A, Takahashi H, Tanaka H, Fujimoto Y, Watabe T, Isohashi K, Hatazawa J, Tomiyama N. Jpn J Radiol; 2017 Oct 01; 35(10):613-621. PubMed ID: 28879406 [Abstract] [Full Text] [Related]
12. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, David P, Desmedt F, Simon S, Van Houtte P, Brotchi J, Goldman S. J Nucl Med; 2004 Jul 01; 45(7):1146-54. PubMed ID: 15235060 [Abstract] [Full Text] [Related]
13. Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience. Grosu AL, Lachner R, Wiedenmann N, Stärk S, Thamm R, Kneschaurek P, Schwaiger M, Molls M, Weber WA. Int J Radiat Oncol Biol Phys; 2003 Aug 01; 56(5):1450-63. PubMed ID: 12873691 [Abstract] [Full Text] [Related]
14. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors. Schinkelshoek M, Lopci E, Clerici E, Alongi F, Mancosu P, Rodari M, Navarria P, van der Hiel B, Scorsetti M, Chiti A. Tumori; 2014 Aug 01; 100(6):636-44. PubMed ID: 25688497 [Abstract] [Full Text] [Related]
15. Target definition by C11-methionine-PET for the radiotherapy of brain metastases. Matsuo M, Miwa K, Shinoda J, Kako N, Nishibori H, Sakurai K, Yano H, Iwama T, Kanematsu M. Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):714-22. PubMed ID: 19095373 [Abstract] [Full Text] [Related]
16. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M. J Neurosurg; 2006 Feb 01; 104(2):238-53. PubMed ID: 16509498 [Abstract] [Full Text] [Related]
17. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Kracht LW, Miletic H, Busch S, Jacobs AH, Voges J, Hoevels M, Klein JC, Herholz K, Heiss WD. Clin Cancer Res; 2004 Nov 01; 10(21):7163-70. PubMed ID: 15534088 [Abstract] [Full Text] [Related]